All lobbying filings

The Conafay Group, LLC

The Conafay Group, LLC filed a Q4 report for Elusys Therapeutics, Inc. on January 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Elusys Therapeutics, Inc. · A therapeutics company that manufactures novel antitoxins for health security needs.

As filed: THE CONAFAY GROUP, LLC for ELUSYS THERAPEUTICS, INC.

All filings by The Conafay Group, LLC · Everything Elusys Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 3

BRYAN SHUY

Previously held: Chief of Staff Rep. Harris; Asst. to Rep. Harris, HouseCmteon Approps; Dep. Asst. Sec and Chief of StaffHHS/Asst.Secretary for Preparedness and Response (ASPR)
DARIN L GARDNER

Previously held: Legislative Correspondent Senator Tim Hutchinson;ResearchAssistant Senate HELP Committee; Chief ofStaffCongresswoman Kay Granger
JOSH NARROW

Previously held: Intern to Senator Casey

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Advocacy for medical countermeasure funding and support.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.